$7.79 1.6%
CYRX Stock Price vs. AI Score
Data gathered: November 5

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Cryoport

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.


Cryoport
Price $7.79
Target Price Sign up
Volume 405,350
Market Cap $353M
Year Range $5.55 - $18.83
Dividend Yield 0%
Analyst Rating 33% buy
Earnings Date November 7 '24
Industry Transportation & Logistics

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '2458M32M25M-78M-75M-1.620
Q1 '2455M33M22M-19M-13M-0.430
Q4 '2357M34M23M-62M-58M-1.310
Q3 '2356M32M24M-13M-7.4M-0.310
Q2 '2357M32M25M-18M-12M-0.420

Insider Transactions View All

Hariri Robert J filed to sell 23,061 shares at $9.5.
August 26 '24
Hariri Robert J filed to sell 23,561 shares at $9.
August 20 '24
Mandalam Ramkumar filed to sell 56,032 shares at $8.
August 6 '24
BERMAN RICHARD J filed to sell 100,000 shares at $13.4.
May 16 '24
ZECCHINI EDWARD J filed to sell 60,051 shares at $13.4.
May 15 '24

What is the Market Cap of Cryoport?

The Market Cap of Cryoport is $353M.

When does Cryoport report earnings?

Cryoport will report its next earnings on November 7 '24.

What is the current stock price of Cryoport?

Currently, the price of one share of Cryoport stock is $7.79.

How can I analyze the CYRX stock price chart for investment decisions?

The CYRX stock price chart above provides a comprehensive visual representation of Cryoport's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cryoport shares. Our platform offers an up-to-date CYRX stock price chart, along with technical data analysis and alternative data insights.

Does CYRX offer dividends to its shareholders?

As of our latest update, Cryoport (CYRX) does not offer dividends to its shareholders. Investors interested in Cryoport should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Cryoport?

Some of the similar stocks of Cryoport are UPS, FedEx, Union Pacific, XPO Logistics, and Castor Maritime.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.